CIK: 0001325083 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value ($000): $135,430 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Biohaven Pharmactl Hldg Co L | 857,494 | $46,631 | 34.4% | $27.10 | — | COM | G11196105 |
| — | Corbus Pharmaceuticals HLDGS | 5,045,870 | $27,550 | 20.3% | $4.99 | — | COM | 21833P103 |
| — | Applied Therapeutics Inc | 467,071 | $12,742 | 9.4% | $8.24 | — | COM | 03828A101 |
| — | Abeona Therapeutics Inc | 2,859,767 | $9,351 | 6.9% | $4.67 | — | COM | 00289Y107 |
| — | Blackstone Group LP | 153,000 | $8,522 | 6.3% | $34.97 | — | COM UNIT LTD | 09253U108 |
| — | Eiger Biopharmaceuticals Inc | 350,238 | $5,219 | 3.9% | $10.44 | — | COM | 28249U105 |
| — | Exicure Inc | 1,277,777 | $3,654 | 2.7% | $2.86 | — | COM | 30205M101 |
| ENTX | Entera Bio Ltd | 1,741,363 | $3,605 | 2.7% | $3.39 | -32.1% | SHS | M40527109 |
| ALDX | Aldeyra Therapeutics Inc | 569,405 | $3,308 | 2.4% | $8.37 | -31.0% | COM | 01438T106 |
| KBA | Kraneshares TR | 96,000 | $3,138 | 2.3% | $31.89 | — | BOSERA MSCI CH | 500767405 |
| — | Centurylink Inc | 220,000 | $2,906 | 2.1% | $12.48 | — | COM | 156700106 |
| AVXL | Anavex Life Sciences Corp | 724,205 | $1,876 | 1.4% | $3.56 | -26.3% | COM NEW | 032797300 |
| DOW | Dow Inc | 30,000 | $1,642 | 1.2% | $36.37 | +0.9% | COM | 260557103 |
| — | Molecular Templates | 113,905 | $1,592 | 1.2% | $4.04 | — | COM | 608550109 |
| — | Soligenix Inc. | 787,830 | $1,142 | 0.8% | $2.11 | — | COM | 834223307 |
| DD | Dupont de Nemours Inc | 15,000 | $963 | 0.7% | $27.24 | -10.0% | COM | 26614N102 |
| CTVA | Corteva Inc | 30,000 | $887 | 0.7% | $25.02 | -2.1% | COM | 22052L104 |
| — | Catasys Inc | 43,034 | $702 | 0.5% | $16.93 | — | COM PAR | 149049504 |